Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease-Reference-Cited by-同舟云学术

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Published:2010-10-27 Issue:1 Volume:53 Page:62-72
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Liaw Yun-Fan,Sheen I-Shyan,Lee Chuan-Mo,Akarca Ulus Salih,Papatheodoridis George V.,Suet-Hing Wong Florence,Chang Ting-Tsung,Horban Andrzej,Wang Chia,Kwan Peter,Buti Maria,Prieto Martin,Berg Thomas,Kitrinos Kathryn,Peschell Ken,Mondou Elsa,Frederick David,Rousseau Franck,Schiff Eugene R.

Publisher

Wiley

Subject

Hepatology

Reference31 articles.

1. Epidemiology and natural history of hepatitis B;McMahon;Semin Liv Dis,2005

2. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepatitis,2004

3. Hepatitis B virus infection;Liaw;Lancet,2009

4. for the Chronic Hepatitis B Guideline Workshop Party of the Asian-Pacific Association for the Study of the Liver. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.;Liaw;Hepatol Int,2008

5. Chronic hepatitis B:;Lok;HEPATOLOGY,2009

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study;The Lancet Gastroenterology & Hepatology;2024-08

2. Challenges for hepatitis B control in Asia‐Pacific areas: Consolidating vaccination and rolling‐out antiviral therapies;Journal of Gastroenterology and Hepatology;2024-02-27

3. Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis;Scandinavian Journal of Gastroenterology;2022-10-13

4. Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B;Hepatology Research;2022-10-04

5. JIGAR SIRROZI KASALLIGINI DAVOLASHDA QO‘LLANILADIGAN "PEGILATLANGAN INTERFERON ALFA-2A (PEG-INF-A)"SINTETIK DORI VOSITASINING KIMYOVIY TARKIBI VA USHBU KASALLIKDA HALQ TABOBATIDA FOYDALANILADIGAN OZIQ-OVQAT QO‘SHILMALARI;Журнал химии товаров и народной медицины;2022-07-26